ETALON – Trademark Portfolio
Entity Type: 03
ETALON holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered and 7 are pending. Notable registered marks include ETALON, ALPHADOG, ETALON DIAGNOSTICS, ETALON EQUINE GENETICS, and KNOW YOUR DOG DOWN TO THE DNA. The owner is based in Menlo Park /#234, CA.
405 El Camino Real
Menlo Park /#234, CA 94025
Showing of trademarks Trademarks
Trademark Classifications
ETALON's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does ETALON have?
ETALON has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 7 pending, 1 abandoned.
What trademark classes does ETALON file in?
ETALON files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 18 (Leather Goods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are ETALON's most well-known trademarks?
ETALON's registered trademark portfolio includes well-known marks such as ETALON, ALPHADOG, ETALON DIAGNOSTICS, ETALON EQUINE GENETICS, and KNOW YOUR DOG DOWN TO THE DNA. These are among 6 currently registered trademarks in the portfolio.
What is ETALON's trademark registration success rate?
ETALON has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 7 applications are pending review.